advanced lung cancer
Showing 1 - 25 of >10,000
Metabolic Response to Food in Advanced Lung Cancer
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Weight loss (%)
- (no location specified)
Jun 30, 2023
Lung Cancer ID (Identity) Study
Not yet recruiting
- Lung Cancer Stage IV
- Advanced lung cancer patients' group
-
Roma, Italy
- +1 more
Oct 4, 2023
Advanced Lung Cancer Trial in Hangzhou (WTX212A injection)
Not yet recruiting
- Advanced Lung Cancer
- WTX212A injection
-
Hangzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Oct 27, 2023
Advanced Lung Cancer Trial in Ulaanbaatar (35 kDa hyaluronan fragment)
Recruiting
- Advanced Lung Cancer
- 35 kDa hyaluronan fragment
-
Ulaanbaatar, MongoliaMongolian National University of Medical Sciences
May 1, 2023
Advanced Breast Cancer, Advanced Lung Cancer Trial (Tumor-infiltrating lymphocytes, IL-2)
Not yet recruiting
- Advanced Breast Cancer
- Advanced Lung Cancer
- Tumor-infiltrating lymphocytes
- IL-2
- (no location specified)
Oct 26, 2023
Lung Cancer, Advanced Cancer, Caregiver Burden Trial in Changsha (Acceptance and Commitment Therapy (ACT) plus health education,
Not yet recruiting
- Lung Cancer
- +2 more
- Acceptance and Commitment Therapy (ACT) plus health education
- Health education
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
May 23, 2023
Stratification for Hospital-diagnosed Advanced Lung Cancer
Not yet recruiting
- Lung Cancer
- (no location specified)
Feb 1, 2023
Lung Cancer Trial in Lexington (Pathways, Enhanced Usual Care)
Not yet recruiting
- Lung Cancer
- Pathways
- Enhanced Usual Care
-
Lexington, KentuckyUniversity of Kentucky
Sep 14, 2023
NSCLC Metastatic Trial in Naestved, Aalborg, Vejle (Circulating tumor DNA treatment monitoring)
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
- Circulating tumor DNA treatment monitoring
-
Naestved, Zealand, Denmark
- +2 more
May 25, 2023
Advanced Lung Cancer Trial in Shanghai (Recombinant humanized anti-BTLA mAb (JS004) injection, Toripalimab, Docetaxel)
Not yet recruiting
- Advanced Lung Cancer
- Recombinant humanized anti-BTLA monoclonal antibody (JS004) injection
- +7 more
-
Shanghai, Shanghai, ChinaShanghai Chest Hospital
Dec 23, 2022
Lung Cancer, Advanced Cancer Trial in Changsha (Acceptance and Commitment Therapy (ACT), Usual care)
Completed
- Lung Cancer
- Advanced Cancer
- Acceptance and Commitment Therapy (ACT)
- Usual care
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 3, 2022
Lung Cancer Trial in Madrid (Microbiota Transplant plus anti PD1 therapy, anti PD1 therapy)
Recruiting
- Lung Cancer
- Microbiota Transplant plus anti PD1 therapy
- anti PD1 therapy
-
Madrid, SpainHospital Universitario Ramón y Cajal
Oct 3, 2022
Advanced Lung Cancer Trial in Boston (High-Intensity Interval Training, Moderate-Intensity Continuous Training)
Not yet recruiting
- Advanced Lung Cancer
- High-Intensity Interval Training
- Moderate-Intensity Continuous Training
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 30, 2023
Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Self-administered survey at hospital
- +2 more
- (no location specified)
Oct 3, 2023
Advanced Lung Cancer, Ovarian Cancer Trial in Changsha, Yangzhou, Shanghai (AL2846 capsule)
Recruiting
- Advanced Lung Cancer
- Ovarian Cancer
- AL2846 capsule
-
Changsha, Hunan, China
- +3 more
Apr 4, 2023
Lung Cancer, Pulmonary Rehabilitation, Exercise Trial (pulmonary rehabilitation exercise)
Not yet recruiting
- Lung Cancer
- +9 more
- pulmonary rehabilitation exercise
- (no location specified)
Mar 6, 2022
Lung Cancer, Nonsmall Cell, Stage IIIA, Lung Cancer Non-Small Cell Stage IIIB, Lung Cancer Non-Small Cell Stage III Trial in
Not yet recruiting
- Lung Cancer, Nonsmall Cell, Stage IIIA
- +4 more
- E-health ecosystem of stepped psychosocial care
- Usual psychosocial care
-
L'Hospitalet De Llobregat, Catalunya, SpainInstitut Català d'Oncologia
Aug 9, 2022
Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated
Enrolling by invitation
- Cardiotoxicity
- +3 more
- Chemoradiation
-
Birmingham, Alabama
- +6 more
Nov 1, 2022
Patient Journey With Advanced Lung Cancer Positive for ALK
Recruiting
- Carcinoma, Non-Small-Cell Lung
-
Fortaleza, Ceará, Brazil
- +4 more
Sep 26, 2022
Early Palliative Care Consult on Quality of Life, Cancer Related
Active, not recruiting
- Lung Cancer
- Non-small Cell Lung Cancer
- QOL Questionnaire
- Caregiver Satisfaction Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 25, 2022
T-Cell Repertoire Sequencing: Assessing Pembrolizumab Efficacy
Not yet recruiting
- Non-small Cell Lung Cancer Metastatic
- (no location specified)
Sep 13, 2023
